Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population‐based case‐control study
Background: Systemic inflammation is associated with vessel wall damage, upregulation of procoagulants, downregulation of anticoagulants, and suppression of fibrinolysis. Autoimmune diseases may therefore increase the risk of venous thromboembolism (VTE). Objectives: To examine whether autoimmune...
Saved in:
| Published in | Journal of thrombosis and haemostasis Vol. 10; no. 5; pp. 815 - 821 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford, UK
Blackwell Publishing Ltd
01.05.2012
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1538-7933 1538-7836 1538-7836 |
| DOI | 10.1111/j.1538-7836.2012.04666.x |
Cover
| Abstract | Background: Systemic inflammation is associated with vessel wall damage, upregulation of procoagulants, downregulation of anticoagulants, and suppression of fibrinolysis. Autoimmune diseases may therefore increase the risk of venous thromboembolism (VTE).
Objectives: To examine whether autoimmune skin and connective tissue diseases are associated with increased VTE risk.
Methods: We conducted this population‐based case–control study in northern Denmark, using administrative databases. From 1999 to 2009, we identified 14 721 VTE cases and 147 210 birth year‐matched, sex‐matched and county‐matched population controls. The date of diagnosis/matching was considered to be the index date for cases and controls. For all study subjects, we identified hospital diagnoses of autoimmune skin or connective tissue diseases between 1977 and the index date. We used conditional logistic regression with adjustment for VTE risk factors to calculate odds ratios and 95% confidence intervals (CIs) for patients with vs. without autoimmune disease. Given the risk‐set sampling design, odds ratios estimate incidence rate ratios (IRRs).
Results: Autoimmune skin disease was not associated with VTE (IRR 1.0; 95% CI 0.9–1.2). Patients with connective tissue disease had an increased VTE risk within 90 days (IRR 2.3; 95% CI 1.5–3.7) and 91–365 days (IRR 2.0; 95% CI 1.5–2.8) after diagnosis, but not thereafter (IRR 1.1; 95% CI 1.0–1.2). Among connective tissue diseases, the greatest overall risk increases were found for juvenile rheumatoid arthritis (IRR 3.0; 95% CI 1.4–6.4) and systemic lupus erythematosus (IRR 2.8; 95% CI 1.7–4.7).
Conclusions: Autoimmune connective tissue disease was associated with an increased risk of VTE within 1 year after diagnosis, whereas skin diseases were not. |
|---|---|
| AbstractList | Systemic inflammation is associated with vessel wall damage, upregulation of procoagulants, downregulation of anticoagulants, and suppression of fibrinolysis. Autoimmune diseases may therefore increase the risk of venous thromboembolism (VTE).
To examine whether autoimmune skin and connective tissue diseases are associated with increased VTE risk.
We conducted this population-based case-control study in northern Denmark, using administrative databases. From 1999 to 2009, we identified 14,721 VTE cases and 147,210 birth year-matched, sex-matched and county-matched population controls. The date of diagnosis/matching was considered to be the index date for cases and controls. For all study subjects, we identified hospital diagnoses of autoimmune skin or connective tissue diseases between 1977 and the index date. We used conditional logistic regression with adjustment for VTE risk factors to calculate odds ratios and 95% confidence intervals (CIs) for patients with vs. without autoimmune disease. Given the risk-set sampling design, odds ratios estimate incidence rate ratios (IRRs).
Autoimmune skin disease was not associated with VTE (IRR 1.0; 95% CI 0.9-1.2). Patients with connective tissue disease had an increased VTE risk within 90 days (IRR 2.3; 95% CI 1.5-3.7) and 91-365 days (IRR 2.0; 95% CI 1.5-2.8) after diagnosis, but not thereafter (IRR 1.1; 95% CI 1.0-1.2). Among connective tissue diseases, the greatest overall risk increases were found for juvenile rheumatoid arthritis (IRR 3.0; 95% CI 1.4-6.4) and systemic lupus erythematosus (IRR 2.8; 95% CI 1.7-4.7).
Autoimmune connective tissue disease was associated with an increased risk of VTE within 1 year after diagnosis, whereas skin diseases were not. Systemic inflammation is associated with vessel wall damage, upregulation of procoagulants, downregulation of anticoagulants, and suppression of fibrinolysis. Autoimmune diseases may therefore increase the risk of venous thromboembolism (VTE).BACKGROUNDSystemic inflammation is associated with vessel wall damage, upregulation of procoagulants, downregulation of anticoagulants, and suppression of fibrinolysis. Autoimmune diseases may therefore increase the risk of venous thromboembolism (VTE).To examine whether autoimmune skin and connective tissue diseases are associated with increased VTE risk.OBJECTIVESTo examine whether autoimmune skin and connective tissue diseases are associated with increased VTE risk.We conducted this population-based case-control study in northern Denmark, using administrative databases. From 1999 to 2009, we identified 14,721 VTE cases and 147,210 birth year-matched, sex-matched and county-matched population controls. The date of diagnosis/matching was considered to be the index date for cases and controls. For all study subjects, we identified hospital diagnoses of autoimmune skin or connective tissue diseases between 1977 and the index date. We used conditional logistic regression with adjustment for VTE risk factors to calculate odds ratios and 95% confidence intervals (CIs) for patients with vs. without autoimmune disease. Given the risk-set sampling design, odds ratios estimate incidence rate ratios (IRRs).METHODSWe conducted this population-based case-control study in northern Denmark, using administrative databases. From 1999 to 2009, we identified 14,721 VTE cases and 147,210 birth year-matched, sex-matched and county-matched population controls. The date of diagnosis/matching was considered to be the index date for cases and controls. For all study subjects, we identified hospital diagnoses of autoimmune skin or connective tissue diseases between 1977 and the index date. We used conditional logistic regression with adjustment for VTE risk factors to calculate odds ratios and 95% confidence intervals (CIs) for patients with vs. without autoimmune disease. Given the risk-set sampling design, odds ratios estimate incidence rate ratios (IRRs). Autoimmune skin disease was not associated with VTE (IRR 1.0; 95% CI 0.9-1.2). Patients with connective tissue disease had an increased VTE risk within 90 days (IRR 2.3; 95% CI 1.5-3.7) and 91-365 days (IRR 2.0; 95% CI 1.5-2.8) after diagnosis, but not thereafter (IRR 1.1; 95% CI 1.0-1.2). Among connective tissue diseases, the greatest overall risk increases were found for juvenile rheumatoid arthritis (IRR 3.0; 95% CI 1.4-6.4) and systemic lupus erythematosus (IRR 2.8; 95% CI 1.7-4.7).RESULTS Autoimmune skin disease was not associated with VTE (IRR 1.0; 95% CI 0.9-1.2). Patients with connective tissue disease had an increased VTE risk within 90 days (IRR 2.3; 95% CI 1.5-3.7) and 91-365 days (IRR 2.0; 95% CI 1.5-2.8) after diagnosis, but not thereafter (IRR 1.1; 95% CI 1.0-1.2). Among connective tissue diseases, the greatest overall risk increases were found for juvenile rheumatoid arthritis (IRR 3.0; 95% CI 1.4-6.4) and systemic lupus erythematosus (IRR 2.8; 95% CI 1.7-4.7).Autoimmune connective tissue disease was associated with an increased risk of VTE within 1 year after diagnosis, whereas skin diseases were not.CONCLUSIONSAutoimmune connective tissue disease was associated with an increased risk of VTE within 1 year after diagnosis, whereas skin diseases were not. Background: Systemic inflammation is associated with vessel wall damage, upregulation of procoagulants, downregulation of anticoagulants, and suppression of fibrinolysis. Autoimmune diseases may therefore increase the risk of venous thromboembolism (VTE). Objectives: To examine whether autoimmune skin and connective tissue diseases are associated with increased VTE risk. Methods: We conducted this population-based case-control study in northern Denmark, using administrative databases. From 1999 to 2009, we identified 14721 VTE cases and 147210 birth year-matched, sex-matched and county-matched population controls. The date of diagnosis/matching was considered to be the index date for cases and controls. For all study subjects, we identified hospital diagnoses of autoimmune skin or connective tissue diseases between 1977 and the index date. We used conditional logistic regression with adjustment for VTE risk factors to calculate odds ratios and 95% confidence intervals (CIs) for patients with vs. without autoimmune disease. Given the risk-set sampling design, odds ratios estimate incidence rate ratios (IRRs). Results: Autoimmune skin disease was not associated with VTE (IRR 1.0; 95% CI 0.9-1.2). Patients with connective tissue disease had an increased VTE risk within 90 days (IRR 2.3; 95% CI 1.5-3.7) and 91-365 days (IRR 2.0; 95% CI 1.5-2.8) after diagnosis, but not thereafter (IRR 1.1; 95% CI 1.0-1.2). Among connective tissue diseases, the greatest overall risk increases were found for juvenile rheumatoid arthritis (IRR 3.0; 95% CI 1.4-6.4) and systemic lupus erythematosus (IRR 2.8; 95% CI 1.7-4.7). Conclusions: Autoimmune connective tissue disease was associated with an increased risk of VTE within 1 year after diagnosis, whereas skin diseases were not. Background: Systemic inflammation is associated with vessel wall damage, upregulation of procoagulants, downregulation of anticoagulants, and suppression of fibrinolysis. Autoimmune diseases may therefore increase the risk of venous thromboembolism (VTE). Objectives: To examine whether autoimmune skin and connective tissue diseases are associated with increased VTE risk. Methods: We conducted this population‐based case–control study in northern Denmark, using administrative databases. From 1999 to 2009, we identified 14 721 VTE cases and 147 210 birth year‐matched, sex‐matched and county‐matched population controls. The date of diagnosis/matching was considered to be the index date for cases and controls. For all study subjects, we identified hospital diagnoses of autoimmune skin or connective tissue diseases between 1977 and the index date. We used conditional logistic regression with adjustment for VTE risk factors to calculate odds ratios and 95% confidence intervals (CIs) for patients with vs. without autoimmune disease. Given the risk‐set sampling design, odds ratios estimate incidence rate ratios (IRRs). Results: Autoimmune skin disease was not associated with VTE (IRR 1.0; 95% CI 0.9–1.2). Patients with connective tissue disease had an increased VTE risk within 90 days (IRR 2.3; 95% CI 1.5–3.7) and 91–365 days (IRR 2.0; 95% CI 1.5–2.8) after diagnosis, but not thereafter (IRR 1.1; 95% CI 1.0–1.2). Among connective tissue diseases, the greatest overall risk increases were found for juvenile rheumatoid arthritis (IRR 3.0; 95% CI 1.4–6.4) and systemic lupus erythematosus (IRR 2.8; 95% CI 1.7–4.7). Conclusions: Autoimmune connective tissue disease was associated with an increased risk of VTE within 1 year after diagnosis, whereas skin diseases were not. |
| Author | HORVÁTH‐PUHÓ, E. SCHMIDT, M. SØRENSEN, H. T. JOHANNESDOTTIR, S. A. |
| Author_xml | – sequence: 1 givenname: S. A. surname: JOHANNESDOTTIR fullname: JOHANNESDOTTIR, S. A. – sequence: 2 givenname: M. surname: SCHMIDT fullname: SCHMIDT, M. – sequence: 3 givenname: E. surname: HORVÁTH‐PUHÓ fullname: HORVÁTH‐PUHÓ, E. – sequence: 4 givenname: H. T. surname: SØRENSEN fullname: SØRENSEN, H. T. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22353382$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVUU1v1DAQtVAR_YC_gHzkssHOOE6MBFJVFdqqEpdythzHEd46doidtitx4CfwG_klOLttD5wWS_aMNe89j98cowMfvEEIU1LQvN6vC1pBs6ob4EVJaFkQxjkvHl6go-fCwVMuAA7RcYxrQqioSvIKHZYlVABNeYR-ns4p2GGYvcHx1nqsfId18N7oZO8MTjbG2eDORqOiidvyZOMtDj2-Mz7MEafvUxjaYPJ2Ng4fsMJjGGenkg3-z6_fbSZmzXzmS5ZOU3A4prnbvEYve-WiefMYT9C3z-c3Zxer669fLs9Or1eaVSVflRWvGyaU0Lpv6xY6qJtKM2AgVGOAq74WXV81ooa-Va1hTJNOgGiJEoxWDE6Q2OnOflSbe-WcHCc7qGkjKZGLo3ItF7PkYpxcHJVbR-VD5r7bcccp_JhNTHKwURvnlDf591mA1oIzDrAPlNKaEyAZ-vYROreD6Z7beRpMBjQ7gJ5CjJPp_6fjT_9QtU3bYaRJWbePwMedwL11ZrP3w_Lq5mLJ4C8TWMwZ |
| CitedBy_id | crossref_primary_10_1016_j_critrevonc_2016_01_007 crossref_primary_10_1097_MPH_0000000000000830 crossref_primary_10_3390_jcm13102790 crossref_primary_10_3899_jrheum_160185 crossref_primary_10_2147_JIR_S482055 crossref_primary_10_1007_s00296_014_3023_1 crossref_primary_10_1007_s00296_017_3735_0 crossref_primary_10_1002_acr_22673 crossref_primary_10_1016_j_thromres_2022_09_009 crossref_primary_10_4103_ijdvl_IJDVL_827_16 crossref_primary_10_1007_s00393_024_01481_3 crossref_primary_10_1007_s11239_014_1050_0 crossref_primary_10_1111_jth_12604 crossref_primary_10_1007_s12016_017_8635_2 crossref_primary_10_1016_j_chest_2024_01_042 crossref_primary_10_1016_j_thromres_2024_109203 crossref_primary_10_1016_j_semarthrit_2015_05_008 crossref_primary_10_1136_annrheumdis_2014_205800 crossref_primary_10_1161_JAHA_123_029740 crossref_primary_10_2106_JBJS_RVW_20_00201 crossref_primary_10_1093_rheumatology_keu408 crossref_primary_10_1055_s_0040_1722270 crossref_primary_10_1373_clinchem_2014_233296 crossref_primary_10_1186_s41927_018_0008_9 crossref_primary_10_3109_14397595_2015_1038456 crossref_primary_10_1186_s12964_023_01044_0 crossref_primary_10_3390_jcm10225412 crossref_primary_10_1093_rheumatology_keab851 crossref_primary_10_1186_s41927_024_00376_9 crossref_primary_10_4081_dr_2025_10257 crossref_primary_10_1097_PAF_0000000000000167 crossref_primary_10_1016_j_chest_2016_09_009 crossref_primary_10_1007_s40744_022_00513_1 crossref_primary_10_1016_j_healun_2021_07_014 crossref_primary_10_1016_j_thromres_2012_08_306 crossref_primary_10_1016_j_cgh_2012_08_018 crossref_primary_10_1097_MOT_0000000000000978 crossref_primary_10_1111_jth_13846 crossref_primary_10_1007_s12325_022_02281_4 crossref_primary_10_1111_1346_8138_16412 crossref_primary_10_1007_s10067_014_2492_7 crossref_primary_10_1136_annrheumdis_2018_214388 crossref_primary_10_1186_s13052_024_01760_4 crossref_primary_10_1002_acr_22039 crossref_primary_10_1016_j_rdc_2022_08_001 crossref_primary_10_1371_journal_pone_0207218 crossref_primary_10_1016_j_ijcard_2021_08_042 |
| Cites_doi | 10.1001/archinte.167.9.935 10.1111/j.1365-2133.2009.09350.x 10.1016/j.jclinepi.2009.03.018 10.1016/S0140-6736(05)71880-8 10.1177/1403494810387965 10.1038/ncprheum0655 10.1097/BOR.0b013e32831de4e7 10.1016/S0140-6736(11)61306-8 10.1055/s-0037-1617146 10.2147/CLEP.S13458 10.1007/s12026-009-8153-2 10.1111/j.1538-7836.2011.04198.x 10.1136/ard.2009.120899 10.1111/j.1365-2133.1979.tb11881.x 10.1016/S0140-6736(04)16004-2 10.3899/jrheum.071244 10.1093/ije/22.6.1189 10.1186/1741-7015-9-1 10.1161/ATVBAHA.108.162545 10.1016/S0140-6736(09)61963-2 10.1371/journal.pone.0018125 10.1097/00130832-200410000-00007 10.1111/j.1538-7836.2011.04354.x 10.1056/NEJM200108023450506 10.1097/00063198-200209000-00015 |
| ContentType | Journal Article |
| Copyright | 2012 International Society on Thrombosis and Haemostasis 2012 International Society on Thrombosis and Haemostasis. |
| Copyright_xml | – notice: 2012 International Society on Thrombosis and Haemostasis – notice: 2012 International Society on Thrombosis and Haemostasis. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 ADTOC UNPAY |
| DOI | 10.1111/j.1538-7836.2012.04666.x |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
| DatabaseTitleList | MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1538-7836 |
| EndPage | 821 |
| ExternalDocumentID | 10.1111/j.1538-7836.2012.04666.x 22353382 10_1111_j_1538_7836_2012_04666_x JTH4666 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Denmark |
| GeographicLocations_xml | – name: Denmark |
| GroupedDBID | --- 05W 29L 2WC 31~ 33P 36B 3SF 4.4 52U 52V 53G 5GY 5VS 66C 8-0 8-1 AAESR AAEVG AALRI AAMMB AAONW AASGY AAXRX AAXUO AAYWO AAZKR ABCUV ABJNI ABXGK ACAHQ ACCZN ACFBH ACGFO ACGFS ACMXC ACPOU ACPRK ACVFH ACXBN ACXQS ADBBV ADCNI ADEOM ADIZJ ADKYN ADMGS ADOZA ADVLN ADXAS ADZMN AEFGJ AEIMD AENEX AEUPX AFBPY AFEBI AFGKR AFJKZ AFPUW AFZJQ AGXDD AHMBA AIACR AIDQK AIDYY AIGII AITUG AIURR AJAOE AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMRAJ AMYDB APXCP ATUGU AZBYB AZVAB BAWUL BHBCM BMXJE BOGZA BRXPI C45 CAG COF CS3 DCZOG DIK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EFKBS EJD F5P FDB FUBAC G-S GODZA HZ~ IHE IX1 KBYEO LATKE LEEKS LH4 LITHE LOXES LUTES LW6 LYRES M41 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ O66 O9- OIG OK1 OVD P2P P2W PQQKQ ROL SUPJJ TEORI TR2 W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WVDHM ZZTAW AAYXX CITATION 1OC 24P A00 AAHHS ABDBF ACCFJ AEEZP AEQDE AFPWT AIWBW AJBDE CGR CUY CVF EAD EAP ECM EIF EMB EMK ESX FIJ IPNFZ NPM P4E SV3 WYJ 7X8 7T5 H94 ADTOC AGCQF UNPAY |
| ID | FETCH-LOGICAL-c4526-2567849a9ccfb7b3d3785c43439a8e36af79df58973fbabe44c0d939b0a941543 |
| IEDL.DBID | UNPAY |
| ISSN | 1538-7933 1538-7836 |
| IngestDate | Tue Aug 19 21:37:37 EDT 2025 Wed Oct 01 13:46:27 EDT 2025 Sat Sep 27 22:32:06 EDT 2025 Thu Jan 02 22:08:50 EST 2025 Thu Apr 24 23:07:00 EDT 2025 Wed Oct 01 05:05:32 EDT 2025 Thu Sep 25 07:35:11 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | 2012 International Society on Thrombosis and Haemostasis. publisher-specific-oa |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4526-2567849a9ccfb7b3d3785c43439a8e36af79df58973fbabe44c0d939b0a941543 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=http://www.jthjournal.org/article/S1538783622062523/pdf |
| PMID | 22353382 |
| PQID | 1011176030 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | unpaywall_primary_10_1111_j_1538_7836_2012_04666_x proquest_miscellaneous_1017964633 proquest_miscellaneous_1011176030 pubmed_primary_22353382 crossref_primary_10_1111_j_1538_7836_2012_04666_x crossref_citationtrail_10_1111_j_1538_7836_2012_04666_x wiley_primary_10_1111_j_1538_7836_2012_04666_x_JTH4666 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | May 2012 2012-05-00 2012-May 20120501 |
| PublicationDateYYYYMMDD | 2012-05-01 |
| PublicationDate_xml | – month: 05 year: 2012 text: May 2012 |
| PublicationDecade | 2010 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: England |
| PublicationTitle | Journal of thrombosis and haemostasis |
| PublicationTitleAlternate | J Thromb Haemost |
| PublicationYear | 2012 |
| Publisher | Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Ltd |
| References | 2011; 379 2004; 363 2007; 167 2010; 15 1979; 101 2009; 21 1993; 22 2002; 8 1999; 46 2004; 4 1995; 157 2011; 39 2011; 6 2010; 63 2001; 345 2011; 9 2009; 36 2010; 47 2005; 365 2011; 70 2008; 28 2010; 375 2009; 161 2005; 94 2007; 3 2010; 2 2010; 30 Källberg (10.1111/j.1538-7836.2012.04666.x_bb0145) 2011; 70 Grainge (10.1111/j.1538-7836.2012.04666.x_bb0040) 2010; 375 Savin (10.1111/j.1538-7836.2012.04666.x_bb0070) 1979; 101 Zöller (10.1111/j.1538-7836.2012.04666.x_bb0050) 2011; 379 Kyrle (10.1111/j.1538-7836.2012.04666.x_bb0010) 2005; 365 Eaton (10.1111/j.1538-7836.2012.04666.x_bb0105) 2010; 47 Andersen (10.1111/j.1538-7836.2012.04666.x_bb0095) 1999; 46 Ramagopalan (10.1111/j.1538-7836.2012.04666.x_bb0045) 2011; 9 Mosbech (10.1111/j.1538-7836.2012.04666.x_bb0130) 1995; 157 Davidson (10.1111/j.1538-7836.2012.04666.x_bb0035) 2001; 345 Langan (10.1111/j.1538-7836.2012.04666.x_bb0060) 2009; 161 Ahlehoff (10.1111/j.1538-7836.2012.04666.x_bb0085) 2011; 6 Xu (10.1111/j.1538-7836.2012.04666.x_bb0025) 2010; 30 Ehrenstein (10.1111/j.1538-7836.2012.04666.x_bb0120) 2010; 2 Severinsen (10.1111/j.1538-7836.2012.04666.x_bb0135) 2010; 63 Romero‐Díaz (10.1111/j.1538-7836.2012.04666.x_bb0065) 2009; 36 Pearce (10.1111/j.1538-7836.2012.04666.x_bb0100) 1993; 22 Mittermann (10.1111/j.1538-7836.2012.04666.x_bb0110) 2004; 4 Tomasson (10.1111/j.1538-7836.2012.04666.x_bb0075) 2009; 21 Harel‐Meir (10.1111/j.1538-7836.2012.04666.x_bb0140) 2007; 3 Goldhaber (10.1111/j.1538-7836.2012.04666.x_bb0015) 2004; 363 Moller (10.1111/j.1538-7836.2012.04666.x_bb0115) 2002; 8 Fox (10.1111/j.1538-7836.2012.04666.x_bb0030) 2005; 94 Huerta (10.1111/j.1538-7836.2012.04666.x_bb0055) 2007; 167 Heit (10.1111/j.1538-7836.2012.04666.x_bb0020) 2008; 28 Undas (10.1111/j.1538-7836.2012.04666.x_bb0080) 2011; 9 Thomsen (10.1111/j.1538-7836.2012.04666.x_bb0150) 2010; 15 Pedersen (10.1111/j.1538-7836.2012.04666.x_bb0090) 2011; 39 Schmidt (10.1111/j.1538-7836.2012.04666.x_bb0125) 2011; 9 |
| References_xml | – volume: 94 start-page: 362 year: 2005 end-page: 5 article-title: The relationship between inflammation and venous thrombosis. A systematic review of clinical studies publication-title: Thromb Haemost – volume: 22 start-page: 1189 year: 1993 end-page: 92 article-title: What does the odds ratio estimate in a case–control study? publication-title: Int J Epidemiol – volume: 375 start-page: 657 year: 2010 end-page: 63 article-title: Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study publication-title: Lancet – volume: 167 start-page: 935 year: 2007 end-page: 43 article-title: Risk factors and short‐term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom publication-title: Arch Intern Med – volume: 30 start-page: 5 year: 2010 end-page: 6 article-title: Inflammation, innate immunity and blood coagulation publication-title: Hamostaseologie – volume: 2 start-page: 273 year: 2010 end-page: 9 article-title: Existing data sources for clinical epidemiology: Aarhus University Prescription Database publication-title: Clin Epidemiol – volume: 161 start-page: 1149 year: 2009 end-page: 52 article-title: A population‐based study of acute medical conditions associated with bullous pemphigoid publication-title: Br J Dermatol – volume: 345 start-page: 340 year: 2001 end-page: 50 article-title: Autoimmune diseases publication-title: N Engl J Med – volume: 379 start-page: 244 year: 2011 end-page: 9 article-title: Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow‐up study from Sweden publication-title: Lancet – volume: 21 start-page: 41 year: 2009 end-page: 6 article-title: Thromboembolic disease in vasculitis publication-title: Curr Opin Rheumatol – volume: 8 start-page: 429 year: 2002 end-page: 34 article-title: What causes sarcoidosis? publication-title: Curr Opin Pulm Med – volume: 6 start-page: e18125 year: 2011 article-title: Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study publication-title: PLoS One – volume: 28 start-page: 370 year: 2008 end-page: 2 article-title: The epidemiology of venous thromboembolism in the community publication-title: Arterioscler Thromb Vasc Biol – volume: 47 start-page: 228 year: 2010 end-page: 31 article-title: The prevalence of 30 ICD‐10 autoimmune diseases in Denmark publication-title: Immunol Res – volume: 4 start-page: 367 year: 2004 end-page: 71 article-title: Autoimmunity and atopic dermatitis publication-title: Curr Opin Allergy Clin Immunol – volume: 363 start-page: 1295 year: 2004 end-page: 305 article-title: Pulmonary embolism publication-title: Lancet – volume: 9 start-page: 1326 year: 2011 end-page: 33 article-title: Non‐steroidal anti‐inflammatory drug use and risk of venous thromboembolism publication-title: J Thromb Haemost – volume: 157 start-page: 3741 year: 1995 end-page: 5 article-title: The national patient registry. Evaluation of data quality publication-title: Ugeskr Laeger – volume: 9 year: 2011 article-title: Risk of venous thromboembolism in people admitted to hospital with selected immune‐mediated diseases: record‐linkage study publication-title: BMC Med – volume: 365 start-page: 1163 year: 2005 end-page: 74 article-title: Deep vein thrombosis publication-title: Lancet – volume: 9 start-page: 870 year: 2011 end-page: 3 article-title: Association between atopic diseases and venous thromboembolism: a case–control study in patients aged 45 years or less publication-title: J Thromb Haemost – volume: 63 start-page: 223 year: 2010 end-page: 8 article-title: Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution publication-title: J Clin Epidemiol – volume: 36 start-page: 68 year: 2009 end-page: 75 article-title: Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset publication-title: J Rheumatol – volume: 101 start-page: 521 year: 1979 end-page: 34 article-title: The events leading to the death of patients with pemphigus and pemphigoid publication-title: Br J Dermatol – volume: 3 start-page: 707 year: 2007 end-page: 15 article-title: Tobacco smoking and autoimmune rheumatic diseases publication-title: Nat Clin Pract Rheumatol – volume: 39 start-page: 22 year: 2011 end-page: 5 article-title: The Danish civil registration system publication-title: Scand J Public Health – volume: 46 start-page: 263 year: 1999 end-page: 8 article-title: The Danish National Hospital Register. A valuable source of data for modern health sciences publication-title: Dan Med Bull – volume: 15 start-page: 4 year: 2010 end-page: 7 article-title: Smoking and skin disease publication-title: Skin Therapy Lett – volume: 70 start-page: 508 year: 2011 end-page: 11 article-title: Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke publication-title: Ann Rheum Dis – volume: 167 start-page: 935 year: 2007 ident: 10.1111/j.1538-7836.2012.04666.x_bb0055 article-title: Risk factors and short‐term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom publication-title: Arch Intern Med doi: 10.1001/archinte.167.9.935 – volume: 161 start-page: 1149 year: 2009 ident: 10.1111/j.1538-7836.2012.04666.x_bb0060 article-title: A population‐based study of acute medical conditions associated with bullous pemphigoid publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2009.09350.x – volume: 46 start-page: 263 year: 1999 ident: 10.1111/j.1538-7836.2012.04666.x_bb0095 article-title: The Danish National Hospital Register. A valuable source of data for modern health sciences publication-title: Dan Med Bull – volume: 63 start-page: 223 year: 2010 ident: 10.1111/j.1538-7836.2012.04666.x_bb0135 article-title: Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2009.03.018 – volume: 365 start-page: 1163 year: 2005 ident: 10.1111/j.1538-7836.2012.04666.x_bb0010 article-title: Deep vein thrombosis publication-title: Lancet doi: 10.1016/S0140-6736(05)71880-8 – volume: 39 start-page: 22 year: 2011 ident: 10.1111/j.1538-7836.2012.04666.x_bb0090 article-title: The Danish civil registration system publication-title: Scand J Public Health doi: 10.1177/1403494810387965 – volume: 3 start-page: 707 year: 2007 ident: 10.1111/j.1538-7836.2012.04666.x_bb0140 article-title: Tobacco smoking and autoimmune rheumatic diseases publication-title: Nat Clin Pract Rheumatol doi: 10.1038/ncprheum0655 – volume: 21 start-page: 41 year: 2009 ident: 10.1111/j.1538-7836.2012.04666.x_bb0075 article-title: Thromboembolic disease in vasculitis publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0b013e32831de4e7 – volume: 379 start-page: 244 year: 2011 ident: 10.1111/j.1538-7836.2012.04666.x_bb0050 article-title: Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow‐up study from Sweden publication-title: Lancet doi: 10.1016/S0140-6736(11)61306-8 – volume: 30 start-page: 5 year: 2010 ident: 10.1111/j.1538-7836.2012.04666.x_bb0025 article-title: Inflammation, innate immunity and blood coagulation publication-title: Hamostaseologie doi: 10.1055/s-0037-1617146 – volume: 94 start-page: 362 year: 2005 ident: 10.1111/j.1538-7836.2012.04666.x_bb0030 article-title: The relationship between inflammation and venous thrombosis. A systematic review of clinical studies publication-title: Thromb Haemost – volume: 2 start-page: 273 year: 2010 ident: 10.1111/j.1538-7836.2012.04666.x_bb0120 article-title: Existing data sources for clinical epidemiology: Aarhus University Prescription Database publication-title: Clin Epidemiol doi: 10.2147/CLEP.S13458 – volume: 47 start-page: 228 year: 2010 ident: 10.1111/j.1538-7836.2012.04666.x_bb0105 article-title: The prevalence of 30 ICD‐10 autoimmune diseases in Denmark publication-title: Immunol Res doi: 10.1007/s12026-009-8153-2 – volume: 9 start-page: 870 year: 2011 ident: 10.1111/j.1538-7836.2012.04666.x_bb0080 article-title: Association between atopic diseases and venous thromboembolism: a case–control study in patients aged 45 years or less publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2011.04198.x – volume: 157 start-page: 3741 year: 1995 ident: 10.1111/j.1538-7836.2012.04666.x_bb0130 article-title: The national patient registry. Evaluation of data quality publication-title: Ugeskr Laeger – volume: 70 start-page: 508 year: 2011 ident: 10.1111/j.1538-7836.2012.04666.x_bb0145 article-title: Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke publication-title: Ann Rheum Dis doi: 10.1136/ard.2009.120899 – volume: 101 start-page: 521 year: 1979 ident: 10.1111/j.1538-7836.2012.04666.x_bb0070 article-title: The events leading to the death of patients with pemphigus and pemphigoid publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.1979.tb11881.x – volume: 363 start-page: 1295 year: 2004 ident: 10.1111/j.1538-7836.2012.04666.x_bb0015 article-title: Pulmonary embolism publication-title: Lancet doi: 10.1016/S0140-6736(04)16004-2 – volume: 36 start-page: 68 year: 2009 ident: 10.1111/j.1538-7836.2012.04666.x_bb0065 article-title: Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset publication-title: J Rheumatol doi: 10.3899/jrheum.071244 – volume: 22 start-page: 1189 year: 1993 ident: 10.1111/j.1538-7836.2012.04666.x_bb0100 article-title: What does the odds ratio estimate in a case–control study? publication-title: Int J Epidemiol doi: 10.1093/ije/22.6.1189 – volume: 9 year: 2011 ident: 10.1111/j.1538-7836.2012.04666.x_bb0045 article-title: Risk of venous thromboembolism in people admitted to hospital with selected immune‐mediated diseases: record‐linkage study publication-title: BMC Med doi: 10.1186/1741-7015-9-1 – volume: 28 start-page: 370 year: 2008 ident: 10.1111/j.1538-7836.2012.04666.x_bb0020 article-title: The epidemiology of venous thromboembolism in the community publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.108.162545 – volume: 375 start-page: 657 year: 2010 ident: 10.1111/j.1538-7836.2012.04666.x_bb0040 article-title: Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study publication-title: Lancet doi: 10.1016/S0140-6736(09)61963-2 – volume: 6 start-page: e18125 year: 2011 ident: 10.1111/j.1538-7836.2012.04666.x_bb0085 article-title: Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study publication-title: PLoS One doi: 10.1371/journal.pone.0018125 – volume: 4 start-page: 367 year: 2004 ident: 10.1111/j.1538-7836.2012.04666.x_bb0110 article-title: Autoimmunity and atopic dermatitis publication-title: Curr Opin Allergy Clin Immunol doi: 10.1097/00130832-200410000-00007 – volume: 9 start-page: 1326 year: 2011 ident: 10.1111/j.1538-7836.2012.04666.x_bb0125 article-title: Non‐steroidal anti‐inflammatory drug use and risk of venous thromboembolism publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2011.04354.x – volume: 345 start-page: 340 year: 2001 ident: 10.1111/j.1538-7836.2012.04666.x_bb0035 article-title: Autoimmune diseases publication-title: N Engl J Med doi: 10.1056/NEJM200108023450506 – volume: 8 start-page: 429 year: 2002 ident: 10.1111/j.1538-7836.2012.04666.x_bb0115 article-title: What causes sarcoidosis? publication-title: Curr Opin Pulm Med doi: 10.1097/00063198-200209000-00015 – volume: 15 start-page: 4 year: 2010 ident: 10.1111/j.1538-7836.2012.04666.x_bb0150 article-title: Smoking and skin disease publication-title: Skin Therapy Lett |
| SSID | ssj0019520 |
| Score | 2.3048568 |
| Snippet | Background: Systemic inflammation is associated with vessel wall damage, upregulation of procoagulants, downregulation of anticoagulants, and suppression of... Systemic inflammation is associated with vessel wall damage, upregulation of procoagulants, downregulation of anticoagulants, and suppression of fibrinolysis.... Background: Systemic inflammation is associated with vessel wall damage, upregulation of procoagulants, downregulation of anticoagulants, and suppression of... |
| SourceID | unpaywall proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 815 |
| SubjectTerms | Adult Aged Anticoagulants Autoimmune diseases Autoimmune Diseases - diagnosis Autoimmune Diseases - epidemiology Autoimmune Diseases - immunology Birth Case-Control Studies case–control study Confidence Intervals Connective tissue diseases Connective Tissue Diseases - diagnosis Connective Tissue Diseases - epidemiology Connective Tissue Diseases - immunology Denmark - epidemiology epidemiology Female Fibrinolysis Hospitals Humans Incidence Inflammation Juvenile rheumatoid arthritis Logistic Models Male Middle Aged Odds Ratio Registries Risk Assessment Risk Factors Sampling Skin diseases Skin Diseases - diagnosis Skin Diseases - epidemiology Skin Diseases - immunology Systemic lupus erythematosus Thromboembolism Thrombosis Time Factors venous thromboembolism Venous Thromboembolism - diagnosis Venous Thromboembolism - epidemiology Venous Thromboembolism - immunology |
| SummonAdditionalLinks | – databaseName: Wiley Online Library - Core collection (SURFmarket) dbid: DR2 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NTttAEB5VHKA9QIG2pLTVInF1FHvXXm9vCBVFSPRQgcTN2j9LUYITNU7_1AOPwDPyJMysHauhqKJVD7FiJ-PE45ndbz3fzAAcao-TXDwoo9jxJBKx0JEROBhmHtGrK-1AlvRo4OxjNrwQp5fpZct_olyYpj5E98CNPCOM1-Tg2sxXnZyclbIQiKGV9HGll2V9wpMxT0PE9lNXSSpWaajQ2IjgIn6V1PPgiVZnqt_g5zPYWFQz_f2rnkxWkW2Ymk62YLy8qIaRMu4vatO3P-7Ve_w_V_0cNlsEy44ak9uGJ77agfWzNka_Cz-PFvV0RGknns3Ho4rpyjFLfJowtLI63GrWRobm4WMiuLNpyb6EirGMejdcmanH12Q0v3rPNJt1jcZur29o6sVz4hZ3WrI9C4VyX8DFyYfz42HU9niILDU3jxBxyVworawtjTTccZmnltJdlc49z3QplSvTXEleGm28EHbgFFdmoBViD8Ffwlo1rfwesDzReZ5K5yiSbNEypVMitT70e9fe9EAu72dh2wLo1IdjUvyyEELlFqTcgpRbBOUW33oQd5KzpgjII2QOliZToMdSGEZXHnVIpLo4lhmOrn_8DuUIZ5z34FVjb90vI6BDjJ4nPUg6A_yLv5UF83q0QHF6PqR3r_9VcB-e0uGGJPoG1urPC_8WgVxt3gUXvQOCsDoP priority: 102 providerName: Wiley-Blackwell |
| Title | Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population‐based case‐control study |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1538-7836.2012.04666.x https://www.ncbi.nlm.nih.gov/pubmed/22353382 https://www.proquest.com/docview/1011176030 https://www.proquest.com/docview/1017964633 http://www.jthjournal.org/article/S1538783622062523/pdf |
| UnpaywallVersion | publishedVersion |
| Volume | 10 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1538-7836 dateEnd: 20241002 omitProxy: true ssIdentifier: ssj0019520 issn: 1538-7933 databaseCode: DIK dateStart: 20030101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1538-7836 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0019520 issn: 1538-7933 databaseCode: AKRWK dateStart: 20030701 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 1538-7933 databaseCode: DR2 dateStart: 20030101 customDbUrl: isFulltext: true eissn: 1538-7836 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0019520 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD7oFhQf6l23aBnB12yTmSST-LaIZSm0iHZhfQpzxbXb7OJmvRQf_An-xv4Sz8lNS0FaHxISMpNJzpyZ882cG8BL5VDIRaEPIit4EEexCnSMk2HqEL1ab0LpaWvg8CidTOODWTL7s3VBVpWfqo8tHZs4wQ0F997T2CSfA85DBO1c7K2svwlbKWmWBrA1PXo7_tBER80CKtdf45r9og1PV4Isu_gIV4hp2oU-6gTTJbR5B25vypX6_lUtFheBbC2J9u_CrPPnaQxQTkabSo_M2eXwjtf9yXuw3aJTNm7K3YcbrnwAtw5b_ftD-DHeVMs5uZQ4tj6Zl0yVlhmylamnTVbV3charc-6fkzG62zp2Zc6GiyjvAyneunwWMzXp6-YYqs-idj5z18kVvGdeMab1pCe1UFwH8F0_83x60nQ5m8IDCUuDxBNySzOVW6M11ILK2SWGHJlzVXmRKq8zK1PslwKr5V2cWxCm4tchypHXBGLxzAol6V7CizjKssSaS1piQ1ynbR5nBhX53JXTg9Bdp1XmDa4OeXYWBR_LXKQtAXRtqBuL-puL74NIeprrpoAH1eo86LjjwJHI6lYVOmQhmQwF0UyxZnzn2XI_zcVYghPGubqW0awhvg740PgPbdd47PSmi2vXKE4OJ7Q1c7_tPYMBtXnjXuOmKzSu7gaecd321H4G-ArMJU |
| linkProvider | Unpaywall |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hIlE48C4sTyNxzWoTO3HMrQKqpXR7QFupN8t2HGnVNLtisy0gDvwEfiO_hBknG7GAUEEcEiVKxkkmM_ZnzwvgufE4yMWjMooLnkQiFiayAjvDzCN6LUo3kiUtDUwOs_GR2D9Oj7tyQBQL0-aH6BfcSDNCf00KTgvSm1pO2kphCOSilQxxqpdlQwSUl8lcR1r66l2fSypWacjR2NLgNH7Tree3LW2OVb8A0GuwvaoX5uO5qapNbBsGp70bUK0_q_VJORmuGjt0n37K-PifvvsmXO9ALNttpe4WXPL1bbgy6cz0d-Dz7qqZzyjyxLPlyaxmpi6YI5ea0LuyJvxt1hmHluEy-bizecnOQtJYRuUbTu3c41bNlqcvmGGLvtbYty9fafTFNnGPJ52_PQu5cu_C0d7r6ctx1JV5iBzVN48QdMlcKKOcK620vOAyTx1FvCqTe56ZUqqiTHMleWmN9UK4UaG4siOjEH4IvgNb9bz294HlicnzVBYFGZMdCqcslEidDyXfjbcDkOsfql2XA51KcVT6h7kQMlcTczUxVwfm6g8DiHvKRZsH5AI0z9Yyo1FpyRJjao88JL-6OJYZdrB_vIfChDPOB3CvFbj-yYjpEKbnyQCSXgL_4rWyIF8XJtD70zEdPfhXwqewPZ5ODvTBm8O3D-Eq3dL6jD6Creb9yj9GXNfYJ0FfvwMa5z4r |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQKxU48C4sTyNxzWoTO3bMrQJWS6EVQq3Um-VXpNVusys229KqB34Cv5FfwoyTjVhAqCAOiRIlk8dkxv4cfzNDyAsToJNLB2WSepYlPOUmsRwaQxEAvfrSDWSJvwb29sXokO8e5Uct_wljYZr8EN0PN_SM2F6jg899ue7k6KwYhYAMrawPIz0h-oAnN7mAwRYCpI9dKqlU5TFFYyMDo_h1Vs9vr7TeVf2CP6-Tq8tqbs5OzXS6Dm1j3zS8SSart2ooKZP-srZ9d_5Twsf_89q3yI0WwtKdxuZukyuhukO29tpJ-rvkYmdZz8YYdxLoYjKuqKk8dUioiW0rreO3pu3U0CIeRoY7nZX0JKaMpVi84djOAizT8eL4JTV03lUa-_blK_a9cE1Yw07LtqcxU-49cjh8c_BqlLRFHhKH1c0TgFyy4Moo50orLfNMFrnDeFdlisCEKaXyZV4oyUprbODcDbxiyg6MAvDB2TbZqGZVeEBokZmiyKX3OJXswDSlVzx3IRZ8N8H2iFx9T-3aDOhYiGOqfxgJgXI1KlejcnVUrv7cI2knOW-ygFxC5vnKZDS4LM7DmCqADpFVl6ZSQPP6x3MwSFgw1iP3G3vr7gyIDkB6kfVI1hngXzyWiOZ1aQG9ezDCrYf_KviMbH14PdTv3-6_e0Su4RkNGfIx2ag_LcMTAHW1fRq99TseOTzW |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD7oFpQ-eL-sqIzga7ZJZjKT-LYUy1JoEezC-hTmFly7zS5utrbigz_B3-gv6Tm5aSlI60NCQmYyyZkzc76ZcwN4qz0KuSgsgsjxOBCR0IEROBlKj-jVFTZUBW0NHBzKyVTsz5LZn60Lsqr8Un1u6djECW4ouPORxib5HMRxiKA95jsrV9yGLUmapQFsTQ8_jD810VHTgMr117hmv2zD05Ugy654hCtEKbvQR51guoI2t-Huplzp8296sbgMZGtJtHcfZp0_T2OAcjzaVGZkv18N73jTn3wA91p0ysZNuYdwy5eP4M5Bq39_DD_Gm2o5J5cSz9bH85Lp0jFLtjL1tMmquhtZq_VZ14_JeJ0tC3ZaR4NllJfhxCw9Hov5-uQd02zVJxH7_fMXiVV8J57xpjWkZ3UQ3Ccw3Xt_tDsJ2vwNgaXE5QGiKZWKTGfWFkYZ7rhKE0uurJlOPZe6UJkrkjRTvDDaeCFs6DKemVBniCsEfwqDcln658DSWKdpopwjLbFFrlMuE4n1dS537c0QVNd5uW2Dm1OOjUX-1yIHSZsTbXPq9rzu9vxsCFFfc9UE-LhGnTcdf-Q4GknFokuPNCSDuShSEmfOf5Yh_1_J-RCeNczVt4xgDfF3Gg8h7rntBp8la7a8doV8_2hCVy_-p7WXMKi-bvwrxGSVed2OvwvCii-s |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Autoimmune+skin+and+connective+tissue+diseases+and+risk+of+venous+thromboembolism%3A+a+population-based+case-control+study&rft.jtitle=Journal+of+thrombosis+and+haemostasis&rft.au=Johannesdottir%2C+S+A&rft.au=Schmidt%2C+M&rft.au=Horv%C3%A1th-Puh%C3%B3%2C+E&rft.au=S%C3%B8rensen%2C+H+T&rft.date=2012-05-01&rft.issn=1538-7836&rft.eissn=1538-7836&rft.volume=10&rft.issue=5&rft.spage=815&rft_id=info:doi/10.1111%2Fj.1538-7836.2012.04666.x&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1538-7933&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1538-7933&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1538-7933&client=summon |